Bayer Beats FCA Suit Over Off-Label Yaz Marketing

Law360, New York (September 5, 2012, 1:21 PM EDT) -- A Texas federal judge on Friday tossed a lawsuit alleging Bayer Schering Pharma AG defrauded Medicaid by touting off-label uses for contraceptive drugs Yasmin and Yaz, saying a supposed whistleblower was not the original source of the claims because they were previously reported by Law360 and other news outlets.

U.S. District Judge Marcia A. Crone granted Bayer’s April 16 motion to dismiss the False Claims Act suit by Pharma Fraud Watch LLC. The group claimed Bayer caused doctors to seek Medicaid reimbursements for off-label prescriptions of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

USA v. Bayer Schering Pharma AG, et al.,


Case Number

1:10-cv-00669

Court

Texas Eastern

Nature of Suit

Other Statutory Actions

Judge

Marcia A. Crone

Date Filed

October 22, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.